SEI Investments’s Eton Pharmaceutcials ETON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.56M Sell
30,232
-4,466
-13% -$227K ﹤0.01% 2101
2026
Q2
$1.26M Sell
34,698
-23,336
-40% -$684K ﹤0.01% 2184
2026
Q1
$1.43M Buy
+58,034
New +$1.01M ﹤0.01% 2174
2021
Q2
– Sell
-73,800
Closed -$540K – 2567
2021
Q1
$540K Sell
73,800
-2,597
-3% -$22.2K ﹤0.01% 1992
2020
Q4
$621K Buy
+76,397
New +$589K ﹤0.01% 1885

Other funds holding ETON

SEI Investments's ETON Position: Q3 2026 in Review

SEI Investments reduced its Eton Pharmaceutcials (ETON) stake by 13% in Q3 2026, selling an estimated $227K and leaving 30,232 shares worth $1.56M. The position accounts for ﹤0.01% of the portfolio, ranked #2101.

SEI Investments first reported a position in ETON in Q4 2020 and has held it in 5 quarters since. 214 funds tracked by Wall St. Rank hold ETON as of Q3 2026.

  • SEI Investments held 30,232 shares of Eton Pharmaceutcials worth $1.56M as of Q3 2026.
  • SEI Investments sold 4,466 Eton Pharmaceutcials shares in Q3 2026, an estimated $227K.
  • Eton Pharmaceutcials made up ﹤0.01% of SEI Investments's portfolio in Q3 2026, its #2101 holding.
  • SEI Investments first reported a position in Eton Pharmaceutcials in Q4 2020 and has held it in 5 quarters since.
  • 214 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q3 2026.

Based on SEI Investments's 13F filing for Q3 2026, filed 10 Nov 2026.